Inter-Departmental Working Group

Slides:



Advertisements
Similar presentations
Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Advertisements

Global Measles and Rubella Strategic Plan
ROTARY INTERNATIONAL The Rotary Foundation— Milestones in Building Better Lives.
Regional Health Focus Rome | 27 – 29 June |1 | Health Focus WHO Regional Perspective FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
بسم الله الرحمن الرحيم. IRAN Vaccination policy for post eradication phase Presented by : A. R.ESTEGHAMATI, MD IRAN EPI Manager.
1 Antivirals in the Draft CDC Pandemic Plan David K. Shay Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention.
U.S. Pandemic Influenza Preparedness and Response: Planning and Activities “The pandemic influenza clock is ticking. We just don’t know what time it is.”
1 Bioterrorism Presentation Sharon F. Grigsby, MBA Executive Director Bioterrorism Preparedness Program Public Health Department of Health Services County.
Role of the laboratory in disease surveillance
1. 2 The Public Health Agency of Canada Pandemic Influenza Preparedness: An Overview Dr. Paul Gully Deputy Chief Public Health Officer Ottawa, 19 January.
Global Action Plan for Laboratory Containment of Wild Polioviruses
Pandemic Influenza Preparedness Kentucky Department for Public Health Department for Public Health.
South-South and Triangular Cooperation in Health Achievements, challenges and priorities for post 2015 Sudan’s Experience Fifth IHP+ Country Health Teams.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
Completing The Endgame Global Polio Eradication
Departmental Perspectives on Viral Hepatitis
1 TB/HIV Project in the Philippines Yumiko Yanase.
Progress Report Global Pandemic Preparedness Beijing Conference January 2006 Dr Margaret Chan Assistant Director-General Communicable Diseases Representative.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Update on activities under laboratory containment of wild Polio viruses in India Dr. Rashmi Arora Scientist G & Head Division of Epidemiology & Communicable.
O. Guidzheva Director of Information Center of Healthcare of MHMI.
Raymond A. Strikas, MD Associate Director for Adult Immunization Immunization Services Division National Immunization Program Coordinating Center for Infectious.
Regional Task Force Hospitals and Health Facilities Safe from Disasters IAP meeting 13 August 2009 Incheon.
National Certification Committee for Polio Eradication Proposed Work Plan Till th IEAG Meeting, New Delhi, March, 2012.
NVAC W. R. Dowdle. Laboratory Containment of Wild Poliovirus in the United States Phase I National Survey and Inventory Final Report January.
THE LOCAL GOVERNMENT SELF ASSESSMENT TOOL (LG-SAT)
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
World Health Organization, Regional Office for The Western Pacific Regional Activities Report and Preparation for the Upcoming Influenza Seasons THE 3rd.
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
Result of gap analysis and framework of action required in coming five months August rd Meeting of National Influenza Centres in the Western.
U.S. Pandemic Influenza Preparedness and Response: Update & Progress Report “The pandemic influenza clock is ticking. We just don’t know what time it is.”
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
The Vermont Department of Health Overview of Pandemic Influenza Regional Pandemic Planning Summits 2006 Guidance Support Prevention Protection.
Sustaining Polio Eradication IEAG March 2012 The experience of polio-free countries with importations of WPV: Implications for India.
PolioPlus: Keep our Promise to Eradicate Polio PolioPlus: Keep our Promise to Eradicate Polio.
Governments of the World New Tools and Tactics New Leadership & Commitments.
TM OPV Stockpiling in the United States Trudy V. Murphy, M.D. National Immunization Program Centers for Disease Control and Prevention February 5, 2003.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
Beirut - May 2009 The Human Impact: Measuring Changes in Client’s lives Barbara Marcussen Microfinance Officer Sanabel 6 th Annual Conference OIKOCREDIT.
Conclusions 3 rd Meeting of National Influenza Centres in the Western Pacific and South East Asia Regions 18 – 20 August 2009 Beijing, China.
Bioterrorism and Emergency Preparedness November 16, 2005 Jon Huss Director, Community Preparedness Section.
Polio Eradication Update, Challenges & Risks World Health Organization 15 March 2012.
Global Polio Eradication Initiative The 'Intensified Effort' 18 May 2008.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Addressing a Range of Transmission Intensity Transmission Intensity (measured as EIR) Infections/ 1000/year 10, Parasite.
WHO Hand Hygiene Self-Assessment Framework Global Survey Summary Report Example by Mrs. Williams For Instructional Purposes Only Information obtained.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
PHDSC Privacy, Security, and Data Sharing Committee Letter to Governors.
NVAC The Global Certification Commission declares the world polio-free when: No wild poliovirus has been found for at least 3 consecutive years.
National Immunization Program (NIP)/Advisory Committee on Immunization Practices (ACIP) Report Stephen L. Cochi, MD, MPH Acting Director, National Immunization.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
February 2015 An introduction to the switch from trivalent to bivalent oral polio vaccines 1.
Module 1 Introduction to the polio endgame rationale and IPV vaccine
Polio and Polio Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention.
APEC Network of Networks Initiative: In Support of Infectious Disease Surveillance Enhancement in the InterSARS period Ann Marie Kimball, MD., MPH School.
Poliovirus containment: Explaining the process Laboratory session LS5: Polio containment and Global Health Security Salon Voltaire Accelerating Progress.
Targeted supplementary immunization
Overview of the Objectives, Expected Outcomes, and Meeting Agenda
POLIOPLUS FACT SHEET Feb 2018
Preparing for the Switch
Polio Eradication Progress & Challenges.
Presentation transcript:

Inter-Departmental Working Group 03-07-02 Polio eradication progress Poliovirus laboratory containment Roles Working Group

The Global Polio Eradication Initiative 1980: WHA declared smallpox eradicated 1988: WHA resolved to eradicate polio Eradication strategy is targeted mass OPV immunization with intense virus surveillance Polio eradication is the largest global public health initiative ever undertaken

Pre-‘Acceleration’ Progress 1988 350 000 cases 1999 7 094 cases Slide 2: What progress have we made? As a result of routine polio immunization, National Immunization Days and house-to-house mopping-up activities, there has been a 90% decline in reported polio cases in the last ten years - from over 30 000 to little over 3000 cases. I want to point out that surveillance has significantly increased since 1988, and the success is therefore probably even more impressive. More important has been the marked reduction in the geographic distribution of wild poliovirus as indicated in red. Polio was endemic on 5 continents and in over 130 countries in 1988, compared with only 50 countries on 2 continents today. Although the vast majority of progress has occurred since only 1995, this is still 50 countries too many. As large geographic areas become polio-free, it is increasingly important to minimize the risk of inadvertent release of wild poliovirus from laboratory stocks. Polio Eradication 14

Intensity of indigenous wild poliovirus transmission in 2001 (11 Countries) Year 2000 (20 countries) Zero wild viruses 1 to 4 wild viruses 5 to 20 wild viruses More than 20 wild viruses Importations Under investigation as of 18 December 2001

Acceleration Impact India as of 30 Nov 2000 1998 1999 2000 2000 1 934 viruses 2000 2000 1 126 viruses 196 viruses 196 viruses Polio Eradication

Polio ‘Last Cases’ Americas Region Luis Fermin Tenorio Peru 1991 Western Pacific Region Mum Chanty Cambodia 1997 European Region Melik Minas Turkey 1998 Polio Eradication

Type 2 polio was last found in October 1999 Polio Eradication

Global eradication of all 3 poliovirus types anticipated by 2005

Laboratory Containment The other half of poliomyelitis eradication Certification of Poliomyelitis eradication requires: Finding and controlling wild poliovirus in human populations + Finding and controlling wild poliovirus in laboratories I think everyone is familiar with the goal of laboratory containment but I will take just a moment in the next few slides to review. What is containment? Containment is the other half of a successful poliomyelitis eradication program. The Regional Certification Commission will soon consider if this region can be declared “polio-free”. Much work has been done to find and control polio virus in the human populations of this region. However, polio virus still exists in this region - in various biomedical laboratories scattered throughout the member countries. Containment is the task of finding and controlling polio virus in those labs to complete the goal of polio eradication.

Wild poliovirus may be reintroduced from the laboratory: In theory, by contaminated clothing, liquid effluents, air exhaust, or improper virus disposal In fact, by an infected laboratory worker, who may go unrecognized

Containment Essential laboratory facilities and biosafety practices to minimize the risks of infection to the worker and the community.

Containment Con: Polio will never be eradicated Pro: Progress thus far indicates polio can be eradicated Con: If polio is eradicated, the risk of reintroducing polio from lab is either small or large Pro: Risk of reintroducing polio from the lab grows with time after eradication

Containment Con: Immunization will never stop Pro: OPV (live) immunization at some point must stop Con: Absolute containment can never be ensured Pro: Effective containment can be achieved

Poliovirus and smallpox virus containment strategies differ Poliovirus task is much larger in numbers of labs and types of infectious materials For smallpox, focus was on destruction and global consolidation For polio, focus is on destruction and appropriate laboratory containment

WHO Global Action Plan: 3 steps to containment Pre eradication: Laboratory survey/clean up and inventory Post eradication: Implement required laboratory biosafety levels Post immunization: Maximum containment strategy depends on immunization strategy

All post eradication immunization scenarios assume: global surveillance adequate vaccine stockpiles emergency response plans

Purpose of the survey Alert labs to impending eradication Encourage disposition of unneeded wild poliovirus materials Establish a National Inventory of laboratories retaining such materials

Purpose of the National Inventory Maintain a current list of laboratories with wild polioviruses Keep laboratories informed of biosafety developments Notify laboratories when polio has been eradicated and need to implement containment requirements

Countries initiating laboratory surveys EUROPEAN REGION: 48 / 51 WESTERN PACIFIC REGION: 36 / 36 SOUTH EAST ASIA REGION: 7 / 10 AFRICAN REGION: To start planning 2002 AMERICAS REGION: 12 / 48 EASTERN MEDITERREAN REGION: 19 / 23 15

Tommy G Thompson, Secretary HHS to “The United States is fully committed …..to the containment of any laboratory material that may harbor specimens of wild poliovirus.” Tommy G Thompson, Secretary HHS to George Alleyne, Director, WHO,AMRO June 2001

Timeline for US National Survey and Inventory

US Biomedical Laboratory Database 10,859 diagnostic 301 university (x #) 1,217 industry (x #) 11 Departmental (x #)

Pilot Surveys, Phase I Category Institution Academic Emory Federal CDC NIH/FDA Hospital Industry Am. Home Products Private State & Local Arizona

Phase I: Lessons Learned Cooperation good in all sectors Customized survey instruments/materials work best Greatest challenge is identifying effective communication channels

Roles of Inter-Departmental Working Group Solidarity-work out issues in advance Advocacy-communicating with constituents Advisory-developing survey strategies for in-house labs Regulatory-modifying test requirements Participatory-joining in pilot surveys, phase II

Pilot Surveys, Phase II Anticipated to begin May 2002 Departments with labs under jurisdiction invited to participate PLCP will provide all customized survey materials Look forward to working with you